The present study aimed to evaluate the prognostic significance of four routinely measured hematological parameters—Hb, CRP, fibrinogen and D-dimer—together with ECOG performance status in patients with lung cancer treated at a regional oncology center in Eastern Europe. Here, GSTM1 is linked to lung cancer.